Clinical Trials › NCT06444113
Active, Not RecruitingPhase 4
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Sponsored by Novartis Pharmaceuticals
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 24
Target enrollment
4
U.S. states
Nov 2024
Start date
Oct 2026
Expected completion
Interventions / Treatments
Ofatunumab
Conditions studied
Multiple Sclerosis
Where this trial is running (4 sites)
Participating MS centers on MS Buddy (4)
UCSF Multiple Sclerosis Center
San Francisco, CA
San Francisco, CA
Brigham Multiple Sclerosis Center
Boston, MA
Boston, MA
MS centers in California
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View California centersMore Phase 4 trials
Browse all Phase 4 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
